We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Employment Appeal Tribunal judgment of Mrs Justice Eady on 20 May 2024.
How to use a before-and-after study to evaluate your digital health product.
Guidance on debt relief orders for debt advisers. To search, press ‘control’ and ‘f’ on your keyboard at the same time. A search box will appear.
Information for manufacturers of medical devices about reporting adverse incidents and field safety corrective actions to the MHRA.
Statement by Ambassador Barbara Woodward at the UN Security Council meeting on security challenges in the Mediterranean.
Change your protocol, update your authorisation, report safety issues, submit safety updates and complete your end-of-trial study report.
If you manage an online platform that allows user generated content, these 7 steps will help you keep your business and your users safe.
How to apply for marketing authorisation via this new procedure.
The UK government's design principles and examples of how they've been used.
This guidance provides information on COVID-19 in homelessness, domestic abuse refuge, respite room and asylum seeker accommodation settings.
A new pathway supporting innovative approaches to the safe, timely and efficient development of medicines to improve patient access.
Explains testing from 1 April 2024 onwards and sets out the purpose of ongoing testing, who will be eligible to access testing and when tests should be used.
Guidance on defining intended purpose for Software as a Medical Device (SaMD), to help SaMD manufacturers in meeting their statutory obligations.
Information for patients, healthcare professionals and developers of new medicines
A guide to farming risks, potential problems with public safety and how to avoid accidents
Guidance for the veterinary pharmaceutical industry on the production of mock-ups for assessment.
The New Active Substance Work Sharing Initiative (NASWSI) has successfully approved several medicines through this international collaboration and continues to foster cooperation and strong relationships between its Access partners. The Biosimilar Work Sharing Initiative (BSWSI) builds on this success.
How investigators and sponsors should manage clinical trials during COVID-19
How to notify the MHRA of your intention to carry out a clinical investigation for medical devices.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).